Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05240885 · ClinicalTrials.gov registry record

Metabolic and Functional Consequences of Aging in Health and Disease

A clinical trial of Aging, sponsored by Texas A&M University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05240885 is a study of Aging that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 100 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05240885, a study of Aging, is actively recruiting participants, sponsored by Texas A&M University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Current knowledge of the aging experience and the trajectories of physical and cognitive decline across various age groups are not well-understood, yet crucial to prevent spending added years in disease. Hence, the study objective is to develop the metabolic profile associated with aging-related disorders measured as the incidence of impaired functional capacity, cognitive function, and/or well-being.

Conditions Studied

Interventions

  • OTHER Stable tracer infusion in a postabsorptive state

Study Locations (1)

Texas

  • Human Clinical Research Building - College Station

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-03-04
Est. Completion 2026-09

Sponsor

Texas A&M University

95 total trials

What the Registry Record Tells You About NCT05240885

The ClinicalTrials.gov registry entry for NCT05240885 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Stable tracer infusion in a postabsorptive state is the first listed.

NCT05240885 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05240885 about?

NCT05240885 is a clinical study titled "Metabolic and Functional Consequences of Aging in Health and Disease". Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Cu...

What is the current status of trial NCT05240885?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-03-04. Estimated completion is 2026-09.

What conditions does trial NCT05240885 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT05240885?

The interventions under investigation include: Stable tracer infusion in a postabsorptive state (OTHER).

Who is sponsoring clinical trial NCT05240885?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05240885 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.